Park Place Capital Corp Bio Rad Laboratories, Inc. Transaction History
Park Place Capital Corp
- $319 Million
- Q3 2024
A detailed history of Park Place Capital Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 68 shares of BIO stock, worth $22,854. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68
Previous 66
3.03%
Holding current value
$22,854
Previous $18,000
22.22%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$641 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$521 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$438 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$365 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$240 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.28B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...